Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
- PMID: 30909619
- PMCID: PMC6468478
- DOI: 10.3390/toxins11030178
Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
Abstract
Staphylococcal enterotoxin B (SEB) and related superantigenic toxins produced by Staphylococcus aureus are potent activators of the immune system. These protein toxins bind to major histocompatibility complex (MHC) class II molecules and specific Vβ regions of T-cell receptors (TCRs), resulting in the activation of both monocytes/macrophages and T lymphocytes. The bridging of TCRs with MHC class II molecules by superantigens triggers an early "cytokine storm" and massive polyclonal T-cell proliferation. Proinflammatory cytokines, tumor necrosis factor α, interleukin 1 (IL-1), IL-2, interferon γ (IFNγ), and macrophage chemoattractant protein 1 elicit fever, inflammation, multiple organ injury, hypotension, and lethal shock. Upon MHC/TCR ligation, superantigens induce signaling pathways, including mitogen-activated protein kinase cascades and cytokine receptor signaling, which results in NFκB activation and the phosphoinositide 3-kinase/mammalian target of rapamycin pathways. In addition, gene profiling studies have revealed the essential roles of innate antimicrobial defense genes in the pathogenesis of SEB. The genes expressed in a murine model of SEB-induced shock include intracellular DNA/RNA sensors, apoptosis/DNA damage-related molecules, endoplasmic reticulum/mitochondrial stress responses, immunoproteasome components, and IFN-stimulated genes. This review focuses on the signaling pathways induced by superantigens that lead to the activation of inflammation and damage response genes. The induction of these damage response genes provides evidence that SEB induces danger signals in host cells, resulting in multiorgan injury and toxic shock. Therapeutics targeting both host inflammatory and cell death pathways can potentially mitigate the toxic effects of staphylococcal superantigens.
Keywords: SEB; damage response; inflammation; staphylococcal superantigens; therapeutics; toxic shock.
Conflict of interest statement
The author declares no conflicts of interest.
Figures
Similar articles
-
Staphylococcal Superantigens Spark Host-Mediated Danger Signals.Front Immunol. 2016 Feb 2;7:23. doi: 10.3389/fimmu.2016.00023. eCollection 2016. Front Immunol. 2016. PMID: 26870039 Free PMC article. Review.
-
FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.Immunotargets Ther. 2017 May 2;6:17-29. doi: 10.2147/ITT.S125429. eCollection 2017. Immunotargets Ther. 2017. PMID: 28497030 Free PMC article. Review.
-
PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.Toxins (Basel). 2012 Nov 15;4(11):1343-66. doi: 10.3390/toxins4111343. Toxins (Basel). 2012. PMID: 23202320 Free PMC article. Review.
-
Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.Toxins (Basel). 2010 Aug;2(8):1963-83. doi: 10.3390/toxins2081963. Epub 2010 Jul 29. Toxins (Basel). 2010. PMID: 22069668 Free PMC article. Review.
-
Chemotherapeutics targeting immune activation by staphylococcal superantigens.Med Sci Monit. 2005 Sep;11(9):RA290-5. Epub 2005 Aug 26. Med Sci Monit. 2005. PMID: 16127375 Review.
Cited by
-
Average nucleotide identity-based Staphylococcus aureus strain grouping allows identification of strain-specific genes in the pangenome.mSystems. 2024 Jul 23;9(7):e0014324. doi: 10.1128/msystems.00143-24. Epub 2024 Jun 27. mSystems. 2024. PMID: 38934646 Free PMC article.
-
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock.Int J Mol Sci. 2024 Jul 7;25(13):7456. doi: 10.3390/ijms25137456. Int J Mol Sci. 2024. PMID: 39000566 Free PMC article.
-
Staphylococcal Toxic Shock Syndrome after Autologous Breast Reconstruction: A Case Report and Literature Review.Plast Reconstr Surg Glob Open. 2022 Dec 19;10(12):e4710. doi: 10.1097/GOX.0000000000004710. eCollection 2022 Dec. Plast Reconstr Surg Glob Open. 2022. PMID: 36569240 Free PMC article.
-
Characterization of Virulence Factors in Enterotoxin-Producing Staphylococcus aureus from Bulk Tank Milk.Animals (Basel). 2022 Jan 26;12(3):301. doi: 10.3390/ani12030301. Animals (Basel). 2022. PMID: 35158625 Free PMC article.
-
Inhibition of the sea Gene Expression in Staphylococcus aureus Using the Aqueous and Alcoholic Extracts of the Grapevine (Vitis vinifera L.) Seeds.Arch Razi Inst. 2022 Feb 28;77(1):269-276. doi: 10.22092/ARI.2021.356364.1830. eCollection 2022 Feb. Arch Razi Inst. 2022. PMID: 35891770 Free PMC article.
References
-
- Kotzin B.L., Leung D.Y.M., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 1993;54:99–166. - PubMed
-
- Langley R.J., Fraser J.D., Proft T. Bacterial superantigens and superantigen-like toxins. In: Alouf J., Ladant D., Popoff M.R., editors. The Comprehensive Sourcebook of Bacterial Protein Toxins. 4th ed. Academic Press; London, UK: 2015. pp. 911–974.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials